Granata Bio

Granata Bio is a biopharma company focused on women's health and infertility. They develop and commercialize innovative fertility medications, addressing unmet needs in the market with a novel approach to clinical development and product design. The company's pipeline includes collaborations spanning four different IVF product classes.

Funding Round: Series A

Funding Amount: $14M

Date: 16-Jan-2024

Investors: GV (Google Ventures), CooperSurgical, Gedeon Richter, Alumni Ventures, Amboy Street Ventures, Vibe Bio

Markets: Biopharma, Women's Health, Infertility, Biotechnology, Pharmaceuticals, Drug Discovery, Life Sciences, FemTech

HQ: Duxbury, Massachusetts, United States

Founded: 2018

Website: https://www.granata.bio/

LinkedIn: https://www.linkedin.com/company/granatabio

Twitter: https://twitter.com/Granata_Bio

Instagram:

Facebook: